Drugs for Bruxism (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 74)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Acetylcholine |
Approved |
Phase 4,Phase 1 |
|
51-84-3 |
187
|
Synonyms:
2-(Acetyloxy)-N,N,N-trimethylethanaminium
Acetilcolina cusi
Acetyl choline ion
Acetylcholine bromide
Acetylcholine cation
acetylcholine chloride
Acetylcholine chloride
Acetylcholine Chloride
Acetylcholine fluoride
Acetylcholine hydroxide
Acetylcholine iodide
Acetylcholine L tartrate
Acetylcholine L-tartrate
Acetylcholine perchlorate
Acetylcholine picrate
Acetylcholine picrate (1:1)
Acetylcholine sulfate (1:1)
Acetylcholinium: acetyl-choline
ACh
|
Alcon brand OF acetylcholine chloride
Azetylcholin
Bournonville brand OF acetylcholine chloride
Bromide, acetylcholine
Bromoacetylcholine
Chloroacetylcholine
Choline acetate
Choline acetate (ester)
Choline acetic acid
Ciba vision brand OF acetylcholine chloride
Cusi, acetilcolina
Fluoride, acetylcholine
Hydroxide, acetylcholine
Iodide, acetylcholine
Iolab brand OF acetylcholine chloride
L-Tartrate, acetylcholine
Miochol
O-Acetylcholine
Perchlorate, acetylcholine
|
|
2 |
|
Trazodone |
Approved, Investigational |
Phase 4 |
|
19794-93-5 |
5533
|
Synonyms:
19794-93-5
2-(3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl)[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one
2-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-[1,2,4]triazolo[4,3-a]pyridin-3-one
2-{3-[4-(3-chlorophenyl)piperazin-1-yl]propyl}[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one
8-[3-[4-(3-Chlorophenyl)piperazin-1-yl]propyl]-1,7,8-triazabicyclo[4.3.0]nona-2,4,6-trien-9-one hydrochloride
AC1L1KK2
AC-6778
apo Trazodone
Apotex brand OF trazodone hydrochloride
Apothecon brand OF trazodone hydrochloride
apo-Trazodone
Aventis brand OF trazodone hydrochloride
Aventis pharma brand OF trazodone hydrochloride
Beneficat
Boehringer ingelheim brand OF trazodone hydrochloride
BPBio1_000248
BRD-K70778732-003-05-1
Bristol myers squibb brand OF trazodone hydrochloride
Bristol-myers squibb brand OF trazodone hydrochloride
BRN 0628010
BSPBio_000224
BSPBio_003040
C07156
C19H22ClN5O
CAS-25332-39-2
CHEBI:9654
CHEMBL621
CID5533
D08626
DB00656
Deprax
Desirel
Desyrel
Desyrel Dividose
Desyrel(trazodone hcl salt)
DivK1c_000196
EINECS 243-317-1
Farma lepori brand OF trazodone hydrochloride
Gen trazodone
Genpharm brand OF trazodone hydrochloride
Gen-trazodone
Hexal brand OF trazodone hydrochloride
I06-1977
IDI1_000196
KBio1_000196
KBio2_001904
KBio2_004472
KBio2_007040
KBio3_002540
KBioGR_001110
KBioSS_001904
L000771
Lopac0_001159
Lopac-T-6154
LS-156735
MLS000758230
Molipaxin
MolPort-003-850-601
NCGC00016035-01
NCGC00016035-02
NCGC00016035-03
|
NCGC00016035-09
NCGC00024405-03
nchembio873-comp51
Neuraxpharm brand OF trazodone hydrochloride
NINDS_000196
novo Trazodone
Novopharm brand OF trazodone hydrochloride
novo-Trazodone
Nu pharm brand OF trazodone hydrochloride
Nu trazodone
Nu-pharm brand OF trazodone hydrochloride
Nu-trazodone
Oprea1_185901
Pharmascience brand OF trazodone hydrochloride
PMS Trazodone
PMS-Trazodone
Prestwick0_000292
Prestwick1_000292
Prestwick2_000292
Prestwick3_000292
ratio Trazodone
Ratiopharm brand OF trazodone hydrochloride
ratio-Trazodone
Searle brand OF trazodone hydrochloride
Sideril
Sidmark brand OF trazodone hydrochloride
SPBio_000867
SPBio_002443
Spectrum_001424
Spectrum2_000854
Spectrum3_001560
Spectrum4_000755
Spectrum5_000974
Thombran
Tradozone
Trazalon
Trazodil
Trazodon
Trazodon hexal
Trazodon neuraxpharm
Trazodona
Trazodona [INN-Spanish]
Trazodona [Spanish]
trazodone
Trazodone
trazodone (Desyrel)
Trazodone (INN)
Trazodone [INN:BAN]
Trazodone Hcl
Trazodone hydrochloride
Trazodon-neuraxpharm
Trazodonum
Trazodonum [INN-Latin]
Trazodonum [Latin]
Trazolan
Trazon
Trazonil
Trialodine
Trittico
Trittico (TN)
UNII-YBK48BXK30
|
|
3 |
|
Lidocaine |
Approved, Vet_approved |
Phase 4 |
|
137-58-6 |
3676
|
Synonyms:
.alpha.-(Diethylamino)-2,6-acetoxylidide
.alpha.-Diethylamino-2,6-dimethylacetanilide
.alpha.-Diethylaminoaceto-2,6-xylidide
.omega.-Diethylamino-2,6-dimethylacetanilide
137-58-6
2-(diethylamino)-2',6'-Acetoxylidide
2-(Diethylamino)-2',6'-acetoxylidide
2-(diethylamino)-N-(2,6-Dimethylphenyl)acetamide
2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide
2-2ETN-2MePhAcN
2-Diethylamino-N-(2,6-dimethylphenyl)acetamide
2-Diethylamino-N-(2,6-dimethyl-phenyl)-acetamide
4-12-00-02538 (Beilstein Handbook Reference)
6108-05-0 (MONOHYDROCHLORIDE MONOHYDRATE))
6108-05-0 (mono-hydrochloride, mono-hydrate)
73-78-9 (mono-hydrochloride)
AB00053581
AC-10282
AC1L1GGQ
AC1Q2Z7J
a-diethylamino-2,6-Dimethylacetanilide
After Burn Double Strength Gel
After Burn Double Strength Spray
After Burn Gel
After Burn Spray
AKOS001026768
alfa-Dietilamino-2,6-dimetilacetanilide
alfa-Dietilamino-2,6-dimetilacetanilide [Italian]
Alphacaine
alpha-diethylamino-2,6-dimethylacetanilide
alpha-diethylamino-2,6-Dimethylacetanilide
alpha-Diethylamino-2,6-dimethylacetanilide
Anestacon
Anestacon Jelly
ARONIS23855
Astrazeneca brand OF lidocaine
BIDD:GT0342
Bio-0767
Bio1_000379
Bio1_000868
Bio1_001357
Bio2_000079
Bio2_000559
BPBio1_000197
BRD-K52662033-001-02-6
BRD-K52662033-003-05-5
BRN 2215784
BSPBio_000179
BSPBio_001359
BSPBio_003004
C07073
C14H22N2O
Cappicaine
CAS-73-78-9
CDS1_000283
CHEBI:6456
CHEMBL79
CID3676
Cito optadren
CPD000058189
Cuivasil
D00358
Dalcaine
DB00281
Dentipatch
Dentipatch (TN)
DermaFlex
Diethylaminoaceto-2,6-xylidide
Dilocaine
DivK1c_000174
DivK1c_001323
Duncaine
EINECS 205-302-8
ELA-Max
EMBOLEX
Emla Cream
Esracaine
FT-0082378
Gravocain
HMS1791D21
HMS1989D21
HMS2051C21
HMS2089E15
HMS548M19
HSDB 3350
I01-2704
IDI1_000174
IDI1_033829
Isicaina
Isicaine
Jenapharm brand OF lidocanine hydrochloride
Jetocaine
KBio1_000174
KBio2_000079
KBio2_001598
KBio2_002647
KBio2_004166
KBio2_005215
KBio2_006734
KBio3_000157
KBio3_000158
KBio3_002224
KBioGR_000079
KBioGR_000599
KBioSS_000079
KBioSS_001598
L0156
L1026_SIGMA
L7757_SIGMA
Lanabiotic
L-Caine
|
Leostesin
Lida-Mantle
Lidocaina
Lidocaina [INN-Spanish]
lidocaine
LIDOCAINE (73-58-6 (MONOHYDROCHLORIDE)
Lidocaine (JP15/USP/INN)
Lidocaine (VAN)
Lidocaine [USAN:INN:JAN]
Lidocaine carbonate
Lidocaine Carbonate
Lidocaine carbonate (2:1)
Lidocaine hydrocarbonate
Lidocaine Hydrocarbonate
Lidocaine hydrochloride
Lidocaine monoacetate
Lidocaine monohydrochloride
Lidocaine Monohydrochloride
Lidocaine monohydrochloride, monohydrate
Lidocaine sulfate (1:1)
Lidocainum
Lidocainum [INN-Latin]
Lidocaton
Lidoderm
Lidoject-1
Lidoject-2
LIDOPEN
Lignocaine
Lignocainum
Lingocaine
Lopac0_000669
Lopac-L-5647
LQZ
LS-805
Maricaine
Maybridge1_002571
MLS000069724
MLS000758263
MLS001074177
MolPort-001-783-478
N-(2,6-dimethylphenyl)-N(2),N(2)-diethylglycinamide
N-(2,6-dimethylphenyl)-N~2~,N~2~-diethylglycinamide
NCGC00015611-01
NCGC00015611-02
NCGC00015611-03
NCGC00015611-04
NCGC00015611-14
NCGC00022176-05
NCGC00022176-06
NCGC00022176-07
NCGC00022176-08
NCGC00022176-09
nchembio.65-comp16
NINDS_000174
Norwood Sunburn Spray
Novocol brand OF lidocaine hydrochloride
NSC 40030
NSC40030
Octocaine
Octocaine-100
Octocaine-50
Prestwick0_000050
Prestwick1_000050
Prestwick2_000050
Prestwick3_000050
Remicaine
Rocephin Kit
Rucaina
S1357_Selleck
SAM001247018
SMR000058189
Solarcaine aloe extra burn relief cream
Solcain
SPBio_001525
SPBio_002100
Spectrum_001118
Spectrum2_001343
Spectrum3_001392
Spectrum4_000070
Spectrum5_001549
STK552033
Strathmann brand OF lidocaine hydrochloride
UNII-98PI200987
WLN: 2N2 & 1VMR B1 F1
Xilina
Xilocaina
Xilocaina [Italian]
Xllina
Xycaine
Xylestesin
Xylesthesin
Xylocain
Xylocaine
Xylocaine (TN)
Xylocaine 5% Spinal
Xylocaine CO2
Xylocaine Dental Ointment
Xylocaine Endotracheal
Xylocaine Test Dose
Xylocaine Viscous
Xylocaine-Mpf
Xylocaine-Mpf with Glucose
Xylocard
Xylocitin
Xyloneural
Xyloneural (free base)
Xylotox
Zilactin-L
Zingo
α-diethylamino-2,6-dimethylacetanilide
|
|
4 |
|
onabotulinumtoxinA |
|
Phase 4,Phase 1 |
|
|
|
5 |
|
Botulinum Toxins |
|
Phase 4,Phase 1 |
|
|
|
6 |
|
Botulinum Toxins, Type A |
|
Phase 4,Phase 1 |
|
|
|
7 |
|
Cholinergic Agents |
|
Phase 4,Phase 1 |
|
|
|
8 |
|
Peripheral Nervous System Agents |
|
Phase 4,Phase 2,Phase 1,Not Applicable |
|
|
|
9 |
|
Neurotransmitter Agents |
|
Phase 4,Phase 2,Phase 1,Not Applicable |
|
|
|
10 |
|
abobotulinumtoxinA |
|
Phase 4,Phase 1 |
|
|
|
11 |
|
Acetylcholine Release Inhibitors |
|
Phase 4,Phase 1 |
|
|
|
12 |
|
Neuromuscular Agents |
|
Phase 4,Phase 1 |
|
|
|
13 |
|
Tranquilizing Agents |
|
Phase 4,Phase 2,Not Applicable |
|
|
|
14 |
|
Central Nervous System Depressants |
|
Phase 4,Phase 2,Not Applicable |
|
|
|
15 |
|
Psychotropic Drugs |
|
Phase 4,Phase 2,Not Applicable |
|
|
|
16 |
|
Anti-Anxiety Agents |
|
Phase 4,Not Applicable |
|
|
|
17 |
|
Serotonin Uptake Inhibitors |
|
Phase 4,Phase 2 |
|
|
|
18 |
|
Antidepressive Agents |
|
Phase 4,Phase 2,Not Applicable |
|
|
|
19 |
|
Serotonin Agents |
|
Phase 4,Phase 2 |
|
|
|
20 |
|
Neurotransmitter Uptake Inhibitors |
|
Phase 4,Phase 2,Not Applicable |
|
|
|
21 |
|
Antidepressive Agents, Second-Generation |
|
Phase 4 |
|
|
|
22 |
|
Diuretics, Potassium Sparing |
|
Phase 4 |
|
|
|
23 |
|
Anesthetics, Local |
|
Phase 4 |
|
|
|
24 |
|
Anti-Arrhythmia Agents |
|
Phase 4 |
|
|
|
25 |
|
Anesthetics |
|
Phase 4 |
|
|
|
26 |
|
Sodium Channel Blockers |
|
Phase 4 |
|
|
|
27 |
|
Serotonin |
Investigational, Nutraceutical |
Phase 4,Phase 2 |
|
50-67-9 |
5202
|
Synonyms:
3-(2-Aminoethyl)-1H-indol-5-ol
3-(2-Aminoethyl)indol-5-ol
3-(b-Aminoethyl)-5-hydroxyindole
5 Hydroxytryptamine
5-HT
5-HTA
5-Hydroxy-3-(b-aminoethyl)indole
5-Hydroxyltryptamine
5-Hydroxytriptamine
5-Hydroxytryptamine
5-Hydroxy-tryptamine
Antemovis
|
DS Substance
Enteramin
Enteramine
Hippophaine
Hydroxytryptamine
Serotonine
sérotonine
thrombocytin
Thrombocytin
thrombotonin
Thrombotonin
|
|
28 |
|
Salicylic acid |
Approved, Investigational, Vet_approved |
Phase 3,Phase 1,Phase 2,Early Phase 1,Not Applicable |
|
69-72-7 |
338
|
Synonyms:
105910_ALDRICH
105910_SIAL
2 Hydroxybenzoic acid
2 Hydroxybenzoic Acid
247588_SIAL
27301_SIAL
2-Carboxyphenol
2-hydroxy(1-14c)benzoic acid
2-Hydroxybenzenecarboxylate
2-Hydroxybenzenecarboxylic acid
2-HYDROXYBENZOate
2-Hydroxybenzoic acid
2-HYDROXYBENZOIC ACID
69-72-7
7681-06-3
8052-31-1
84210_FLUKA
84210_SIAL
AB1002436
AC1L190M
AC1Q1HCK
AC1Q72IF
Acid, 2-hydroxybenzoic
Acid, 2-Hydroxybenzoic
Acid, o-Hydroxybenzoic
Acid, O-hydroxybenzoic
Acid, ortho-hydroxybenzoic
Acid, ortho-Hydroxybenzoic
Acid, salicylic
Acid, Salicylic
Acido o-idrossibenzoico
Acido o-idrossibenzoico [Italian]
Acido salicilico
Acido salicilico [Italian]
Acidum salicylicum
Advanced pain relief callus removers
Advanced pain relief corn removers
AI3-02407
AKOS000118979
Akurza Cream
Akurza Lotion
Alpha/Beta Hydroxy Acids (Glycolic Acid, Salicylic Acid)
ALPHA/BETA HYDROXY ACIDS (SALICYLIC ACID) (SEE ALPHA/BETA HYDROXY ACIDS)
AR-1E2203
ATA fraction 10, ammonium salt
Benzoic acid, 2-hydroxy- (9CI)
BENZOIC ACID,2-HYDROXY SALICYLIC ACID
BIDD:ER0602
bmse000252
BRN 0774890
C00805
Caswell No. 731
CCRIS 6714
CHEBI:16914
CHEMBL424
CID338
Clear away wart remover
CMC_13852
Compound w
Compound W
D00097
D020156
DB00936
DHS Sal Shampoo
DivK1c_000301
Domerine
Dr. scholl's callus removers
Dr. Scholl's callus removers
Dr. scholl's corn removers
Dr. Scholl's corn removers
Dr. scholl's wart remover kit
Dr. Scholl's wart remover kit
Duofil wart remover
Duofilm
Duoplant
DuoPlant Gel
E9A559BE-383B-4F83-BC02-3031D03D558A
EINECS 200-712-3
EPA Pesticide Chemical Code 076602
Freezone
H0206
HSDB 672
Hydrisalic Gel
I04-0192
IDI1_000301
InChI=1/C7H6O3/c8-6-4-2-1-3-5(6)7(9)10/h1-4,8H,(H,9,10
Ionil
Ionil plus
Ionil-Plus
K 537
|
K 557
KBio1_000301
KBio2_001428
KBio2_003996
KBio2_006564
KBioSS_001428
Keralyt
Kyselina 2-hydroxybenzoova
Kyselina 2-hydroxybenzoova [Czech]
Kyselina salicylova
Kyselina salicylova [Czech]
LS-2169
Mediplast pads
MLS000069653
MolPort-001-769-476
NCGC00159447-02
NCGC00159447-04
NINDS_000301
NSC 180
NSC180
NSC629474
o Hydroxybenzoic Acid
O Hydroxybenzoic acid
o-Carboxyphenol
O-carboxyphenol
O-Carboxyphenol
Occlusal
O-Hydroxybenzoate
o-hydroxybenzoic acid
O-hydroxybenzoic acid
O-Hydroxybenzoic acid
Oprea1_040343
ortho Hydroxybenzoic acid
ortho Hydroxybenzoic Acid
ortho-Hydroxybenzoic acid
ortho-Hydroxybenzoic Acid
Orthohydroxybenzoic acid
P&S Shampoo
phenol derivative, 7
Phenol-2-carboxylate
Phenol-2-carboxylic acid
Propa pH Peel-Off Acne Mask
Psoriacid-S-stift
Retarder SAX
Retarder W
Rutranex
S5922_SIGMA
S7401_SIGMA
S8519_SIGMA
Salex Cream
Salex Lotion
Salicyclic acid
salicylate
Salicylate
salicylic acid
Salicylic acid & Sulfur Soap
Salicylic acid (6CI,8CI)
Salicylic acid (JP15/USP)
SALICYLIC ACID (SEE ALSO ALPHA HYDROXY ACIDS)
Salicylic acid (TN)
Salicylic acid [USAN:JAN]
Salicylic acid collodion
Salicylic acid soap
SALICYLIC ACID, ACS
Salicylic acid, tech
Salicylic acid, tech.
Salicylic acid-ring-UL-14C
Saligel
Salonil
SAX
SBB052826
Sebucare
Sebulex
SGCUT00012
SMP2_000145
SMR000059163
Spectrum_000948
STK258681
Stri-dex
Stri-Dex
to_000004
trans-Ver-sal
Trans-Ver-Sal
UNII-O414PZ4LPZ
UPCMLD-DP126
UPCMLD-DP126:001
Verrugon
W398500_ALDRICH
WLN: QVR BQ
|
|
29 |
|
Lemon Balm |
|
Phase 3 |
|
|
|
30 |
|
Poke |
|
Phase 3 |
|
|
|
31 |
|
Miconazole |
Approved, Investigational, Vet_approved |
Phase 1, Phase 2,Phase 2,Early Phase 1,Not Applicable |
|
22916-47-8 |
4189
|
Synonyms:
(+-)-1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-(2,4-dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl) imidazole
1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-[2-(2,4-dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole
1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole
1-[2-(2,4-Dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-1H-imidazole
1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole
1-[2-(2,4-dichlorophenyl)-2-{[(2,4-dichlorophenyl)methyl]oxy}ethyl]-1H-imidazole
1-[2,4-Dichloro- beta-([2,4-dichloro- benzyl]oxy)phenethyl]imidazole
1-{2-[(2,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole
22832-87-7 (NITRATE)
22916-47-8
75319-47-0
AB00053500
AC1L1HM1
Aflorix(nitrate)
AKOS001574474
Albistat(nitrate)
Andergin(nitrate)
BPBio1_000279
BRD-A82396632-001-03-0
BRD-A82396632-008-02-7
Brentan
BRN 0965511
BSPBio_000253
BSPBio_002033
CCRIS 7924
CHEBI:6923
CHEMBL91
CID4189
Conofite(nitrate)
CPD-4501
D00416
Dactarin
Daktarin iv
Daktarin IV
DB01110
DivK1c_000156
EINECS 245-324-5
Epi-Monistat(nitrate)
Esteve brand OF miconazole
Femizol-M
Florid(nitrate)
Gyno-Daktar(nitrate)
HMS1568M15
HMS2090B21
I14-14342
IDI1_000156
imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl) methoxy)ethyl)- (9CI)
Imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl)methoxy)ethyl)- (9CI)
Janssen cilag brand OF miconazole
Janssen-cilag brand OF miconazole
Johnston and johnston brand OF miconazole nitrate
KBio1_000156
KBio2_001445
KBio2_004013
KBio2_006581
KBio3_001533
KBioGR_000581
KBioSS_001445
Lotrimin AF(nitrate)
LS-78378
MCZ
Micantin (nitrate)
Miconasil nitrate
Miconasil Nitrate
Miconazol
|
Miconazol [INN-Spanish]
miconazole
Miconazole
Miconazole (JP15/USP/INN)
Miconazole [USAN:BAN:INN:JAN]
Miconazole 3
Miconazole 3 Combination Pack
Miconazole 7 Combination Pack
Miconazole esteve brand
Miconazole janssen-cilag brand
Miconazole nitrate
Miconazole nitrate salt
Miconazole-7
Miconazolo
Miconazolo [DCIT]
Miconazolum
Miconazolum [INN-Latin]
Micozole
Minostate
MJR 1762
MLS002222203
MolPort-002-557-553
Monazole 7
Monista (nitrate)
Monistat
Monistat (TN)
Monistat 1 Combination Pack
Monistat 3 Dual-Pak
Monistat 3 Vaginal Ovules
Monistat 5 Tampon
Monistat 7 Dual-Pak
Monistat 7 Vaginal Suppositories
Monistat Dual- PAK
Monistat IV
Monistat iv (tn)
Monistat iv (TN)
Monistat-Derm
NCI60_001353
NCI60_001380
NINDS_000156
Nitrate, miconasil
Nitrate, miconazole
Novo-Miconazole Vaginal Ovules
NSC 170986
NSC169434
NSC170986
Oprea1_091955
Prestwick_335
Prestwick0_000067
Prestwick1_000067
Prestwick2_000067
Prestwick3_000067
R 18134
R-14,889
SMR001307249
SPBio_000976
SPBio_002174
Spectrum_000965
Spectrum2_001048
Spectrum3_000507
Spectrum4_000061
Spectrum5_001297
STK834405
STOCK1S-93556
UNII-7NNO0D7S5M
Vusion
Zimycan
|
|
32 |
|
Hydrocortisone acetate |
Approved, Vet_approved |
Phase 2,Early Phase 1 |
|
50-03-3 |
|
Synonyms:
21-O-acetylcortisol
Cortisol 21-acetate
|
Hydrocortisone 21-acetate
|
|
33 |
|
Hydrocortisone |
Approved, Vet_approved |
Phase 2,Early Phase 1 |
|
50-23-7 |
5754
|
Synonyms:
(11b)-11,17,21-Trihydroxypregn-4-ene-3,20-dione
(11beta)-11,17,21-Trihydroxypregn-4-ene-3,20-dione
(11β)-11,17,21-trihydroxypregn-4-ene-3,20-dione
[3H]cortisol
11 Epicortisol
11a-Hydroxycorticosterone
11alpha-Hydroxycorticosterone
11b,17,21-Trihydroxyprogesterone
11b,17a,21-Trihydroxy-4-pregnene-3,20-dione
11beta,17,21-Trihydroxyprogesterone
11beta,17alpha,21-Trihydroxy-4-pregnene-3,20-dione
11beta-hydrocortisone
11beta-Hydrocortisone
11-beta-Hydrocortisone
11beta-Hydroxycortisone
11-beta-Hydroxycortisone
11b-Hydrocortisone
11b-Hydroxycortisone
11-Epicortisol
11-Hydrocortisone
11β,17α,21-trihydroxy-4-pregnene-3,20-dione
11β-hydrocortisone
17a-Hydroxycorticosterone
17alpha-Hydroxycorticosterone
17-Hydroxycorticosterone
2v95
4-Pregnen-11b,17a,21-triol-3,20-dione
4-Pregnen-11beta,17alpha,21-triol-3,20-dione
4-pregnen-11β,17α,21-triol-3,20-dione
4-Pregnen-11β,17α,21-triol-3,20-dione
4-Pregnene-11alpha,21-triol 3,20-dione
4-Pregnene-11b,17a,21-triol-3,20-dione
50-23-7
8056-08-4
80562-38-5
8063-42-1
AC-12902
AC1L1L2B
ACETASOL HC
ACETIC ACID W/ HYDROCORTISONE
Acticort
Acticort (TN)
Aeroseb HC
Aeroseb-HC
AI3-25006
AKOS001582651
Alacort
Ala-cort
Ala-Cort
Ala-scalp
Ala-Scalp
Algicirtis
Alphaderm
Amberin
Anflam
Anti-inflammatory hormone
Anucort
Anucort-HC
Anusol HC
Anusol HC (TN)
Anusol-HC
Aquacort
Aquanil HC
B48448A1-24BA-47CA-8D9E-43E5BC949386
Balneol-hc
Balneol-HC
Barseb HC
Basan-corti
Basan-Corti
Beta-hc
Beta-HC
b-HC
Bio-0648
BPBio1_000544
BRD-K93568044-001-03-1
BSPBio_000494
C00735
C21H30O5
CaldeCORT spray
CaldeCORT Spray
CCRIS 5854
Cetacort
CHEBI:17650
CHEMBL389621
Chronocort
CID5754
Clear aid
Cleiton
Cobadex
Colocort
Colocort (TN)
component of Lubricort
component of Neo-Cort-Dome
component of Otalgine
Compound F
Compound F (kendall)
Corhydron
Cor-oticin
COR-OTICIN
Cortanal
Cor-tar-quin
Cort-dome
Cort-Dome
Cortef
Cortef (TN)
Cortenema
Cortesal
Corticreme
Cortifair
Cortifan
Cortifoam
Cortiment
Cortisol
Cortisol alcohol
Cortisol, Hydrocortisone
Cortisolonum
Cortisporin
Cortisporin otico
Cortisporin Otico
Cortispray
Cortizol
Cortolotion
Cortonema
Cortoxide
Cort-quin
Cortril
CORTRIL
CPD000653523
Cremesone
Cremicort-H
Cutisol
Cyclodextrin-encapsulated hydrocortisone
D00088
DB00741
DB07886
Delacort
Dermacort
Derm-aid
Derm-Aid
Dermaspray
Dermil
Dermocortal
Dermolate
Dihydrocostisone
Dioderm
Dome-cort
Domolene-HC
Drotic
DuoCort
Ef corlin
Efcorbin
Efcortelan
Efcortelin
EINECS 200-020-1
Eldecort
Eldercort
Epicort
Epicortisol
Epiderm H
Esiderm H
EU-0100594
Evacort
Ficortril
Fiocortril
Flexicort
Foille insetti
Foille Insetti
Genacort
Genacort (lotion)
Glycort
gyno-Cortisone
Gyno-Cortisone
H 4001
H0135_SIGMA
H0396_SIGMA
H0888_SIGMA
H3160_SIGMA
|
H4001_SIGMA
H6909_SIGMA
HC
HC #1
HC #4
HC (HYDROCORTISONE)
H-Cort
Heb cort
Heb Cort
Heb-cort
Heb-Cort
Hi-cor
Hidalone
hidro-Colisona
Hidro-Colisona
Hidrocortisona
Hidrocortisona [INN-Spanish]
HMS1569I16
HMS2090M04
HSDB 3339
Hycort
Hycortol
Hycortole
Hydracort
Hydrasson
hydro-Adreson
Hydro-Adreson
hydro-Colisona
Hydro-Colisona
Hydrocort
Hydrocortal
Hydrocorticosterone
hydrocortisone
Hydrocortisone
Hydrocortisone (JP15/USP/INN)
Hydrocortisone [INN:BAN:JAN]
Hydrocortisone acetate
Hydrocortisone alcohol
HYDROCORTISONE AND ACETIC ACID
Hydrocortisone base
Hydrocortisone butyrate
Hydrocortisone free alcohol
Hydrocortisone in absorbase
HYDROCORTISONE IN ABSORBASE
Hydrocortisone sodium phosphate
Hydrocortisone solution
Hydrocortisone valerate
Hydrocortisone, (11 alpha)-isomer
Hydrocortisone, (9 beta,10 alpha,11 alpha)-isomer
Hydrocortisone-Water Soluble
Hydrocortisonum
Hydrocortisonum [INN-Latin]
Hydrocortistab
Hydrocortisyl
Hydrocortone
HYDROCORTONE
hydro-RX
Hydro-RX
Hydroskin
Hydroxycortisone
Hysone
Hytisone
Hytone
Hytone (TN)
Hytone lotion
Idrocortisone
Idrocortisone [DCIT]
Incortin-H
Incortin-hydrogen
Kendall's compound F
Komed HC
Kyypakkaus
Lacticare HC
Lacticare-HC
Lactisona
LMST02030001
Locoid
Lopac0_000594
LS-7439
Lubricort
Maintasone
Medicort
Meusicort
Micort-HC
Mildison
Milliderm
MLS000069609
MLS001148103
MLS002207135
MLS002222189
MolPort-001-794-637
NCGC00022848-06
NCGC00022848-07
NCGC00022848-09
NCGC00022848-12
NCI60_000118
neo-Cort-dome
neo-Cortef
Neo-Cortef
Neosporin-H ear
Neosporin-H Ear
Nogenic HC
NSC 10483
NSC10483
NSC-10483
Nutracort
Nystaform-HC
Ophthocort
Optef
ORLEX HC
Otalgine
Otic-neo-cort-dome
Otobiotic
Otocort
Otosone-F
Pediotic suspension
Pediotic Suspension
Penecort
Permicort
Plenadren
Polcort H
Preparation H hydrocortisone cream
Preparation H Hydrocortisone Cream
Prepcort
Prestwick_265
Prestwick0_000447
Prestwick1_000447
Prestwick2_000447
Prestwick3_000447
Prevex HC
Proctocort
Proctofoam
Proctozone HC
Protocort
Racet
Rectasol-HC
Rectoid
Reichstein's substance m
Reichstein's substance M
Remederm HC
S1696_Selleck
SAM002264617
Sanatison
Scalp-Cort
Scalpicin capilar
Scalpicin Capilar
Schericur
Scheroson F
Sigmacort
Signef
SMP1_000156
SMR000059022
SMR000653523
SPBio_002433
Stie-cort
Stiefcorcil
Synacort
Systral hydrocort
Systral Hydrocort
Tarcortin
Terra-cortril
Texacort
Texacort lotion 25
Timocort
Topicort
Transderma H
Traumaide
U-cort
Uniderm
UNII-WI4X0X7BPJ
UPCMLD-DP133
UPCMLD-DP133:001
Vioform-hydrocortisone
VoSol HC
Vytone
Zenoxone
β-HC
|
|
34 |
|
Dopamine |
Approved |
Phase 2,Not Applicable |
|
51-61-6, 62-31-7 |
681
|
Synonyms:
(3H)-Dopamine
.alpha.-(3,4-Dihydroxyphenyl)-.beta.-aminoethane
.Beta.-(3,4-Dihydroxyphenyl)ethylamine hydrochloride
1,2-Benzenediol, 4-(2-aminoethyl)- (9CI)
1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride
1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium
153C5321-5FEE-4B0B-8925-F388F0EEEBD1
2-(3,4-dihydroxyphenyl)ethylamine
2-(3,4-Dihydroxyphenyl)ethylamine
2-benzenediol
3,4 Dihydroxyphenethylamine
3,4-dihydroxyphenethylamine
3,4-Dihydroxyphenethylamine
3,4-Dihydroxyphenethylamine hydrochloride
3,4-Dihydroxyphenylethylamine
3-Hydroxtyramine
3-Hydroxytyramine
3-Hydroxytyramine Hydrobromide
3-Hydroxytyramine hydrochloride
4-(2-Aminoethyl)-1,
4-(2-aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)-1,2-bezenediol
4-(2-Aminoethyl)benzene-1,2-diol
4-(2-aminoethyl)catechol
4-(2-Aminoethyl)catechol
4-(2-aminoethyl)pyrocatechol
4-(2-aminoethyl)-pyrocatechol
4-(2-Aminoethyl)pyrocatechol
4-(2-Aminoethyl)-pyrocatechol
4-(2-Aminoethyl)pyrocatechol hydrochloride
50444-17-2
51-61-6
62-31-7 (HYDROCHLORIDE)
a-(3,4-Dihydroxyphenyl)-b-aminoethane
AC1L19S5
AC1Q54AX
AC1Q54AY
AKOS003790978
alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane
ASL 279
BIDD:ER0506
Biomol-NT_000001
BPBio1_001123
BSPBio_001932
C03758
CHEBI:18243
CHEMBL59
CID681
cMAP_000036
cMAP_000065
D07870
DB00988
Deoxyepinephrine
DivK1c_000780
Dopamin
Dopamina
Dopamina [INN-Spanish]
dopamine
Dopamine
Dopamine (INN)
Dopamine (USAN)(*hydrochloride*)
Dopamine [INN:BAN]
Dopamine hydrochloride
Dopaminum
Dopaminum [INN-Latin]
Dopastat
Dophamine
Dynatra
EINECS 200-110-0
HSDB 3068
Hydrochloride, dopamine
|
Hydroxytyramin
hydroxytyramine
Hydroxytyramine
IDI1_000780
intropin
Intropin
Intropin [*hydrochloride*]
IP 498
KBio1_000780
KBio2_001492
KBio2_002388
KBio2_002484
KBio2_004060
KBio2_004956
KBio2_005052
KBio2_006628
KBio2_007524
KBio2_007620
KBio3_001152
KBio3_002867
KBio3_002962
KBioGR_001129
KBioGR_002388
KBioGR_002484
KBioSS_001492
KBioSS_002393
KBioSS_002491
KW-3-060
L000232
L-DOPAMINE
LDP
Lopac0_000586
Lopac-H-8502
LS-159
Medopa (TN)
m-Hydroxytyramine hydrochloride
MolPort-001-641-000
NCGC00015519-01
NCGC00015519-08
NCGC00096050-01
NCGC00096050-02
NCGC00096050-03
NCGC00096050-04
NCGC00096050-05
nchembio.105-comp9
nchembio.107-comp4
nchembio.284-comp1
nchembio.78-comp16
nchembio.89-comp3
nchembio705-8
nchembio801-comp8
NINDS_000780
NSC 173182
NSC169105
NSC173182
Oprea1_088821
Oxytyramine
Pyrocatechol, 4-(2-aminoethyl)- (8CI)
Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride
Revimine
Revivan
SPBio_001205
Spectrum_001012
SPECTRUM1505155
Spectrum2_001023
Spectrum3_000406
Spectrum4_000525
Spectrum5_000945
ST048774
STK301601
UNII-VTD58H1Z2X
UPCMLD0ENAT5885989:001
|
|
35 |
|
Norepinephrine |
Approved |
Phase 2 |
|
51-41-2 |
439260
|
Synonyms:
(-)-(R)-Norepinephrine
(-)-alpha-(Aminomethyl)protocatechuyl alcohol
(-)-Arterenol
(-)-Arterenol free base
(-)-Noradrenaline
(-)-NORADRENALINE
(-)-Norepinephrine
(R)-(-)-Norepinephrine
(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol
(R)-4-(2-Amino-1-hydroxyethyl)-1,2-benzenediol
(R)-Noradrenaline
(R)-Norepinephrine
1,2-Benzenediol, 4-(2-amino-1-hydroxyethyl)-, (R)- (9CI)
4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol
4-[(1R)-2-amino-1-Hydroxyethyl]-1,2-benzenediol
4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol
4-[(1R)-2-amino-1-hydroxyethyl]benzene-1,2-diol
4899-05-2
51-40-1 (l-tartrate (1:1))
51-41-2
66197-73-7
A7257_SIGMA
Abbott brand OF levophed bitartrate
AC1L96ZT
Adrenor
Aktamin
ALBB-006229
Arterenol
Aventis brand OF norepinephrine hydrochloride
Bitartrate, levophed
Bitartrate, noradrenaline
Bitartrate, norepinephrine
bmse000404
BRN 4231961
BSPBio_002079
C00547
CHEBI:18357
CHEMBL1437
CID439260
D-(-)-Noradrenaline
D00076
D53D5E3A-2360-4CA9-8031-6C2CD4062FD5
DB00368
DivK1c_000230
EINECS 200-096-6
HMS1920B08
HMS2089E18
HMS2091J08
HMS500L12
Hydrochloride, norepinephrine
IDI1_000230
KBio1_000230
KBio2_001489
KBio2_004057
KBio2_006625
KBio3_001579
KBioGR_000635
KBioSS_001489
l-1-(3,4-Dihydroxyphenyl)-2-aminoethanol
l-2-Amino-1-(3,4-dihydroxyphenyl)ethanol
L-2-amino-1-(3,4-Dihydroxyphenyl)ethanol
L-3,4-dihydroxyphenylethanolamine
L-3,4-Dihydroxyphenylethanolamine
L-alpha-(aminomethyl)-3,4-dihydroxybenzyl alcohol
L-alpha-(Aminomethyl)-3,4-dihydroxybenzyl alcohol
L-arterenol
L-Arterenol
Levarterenol
Levarterenolo
Levarterenolo [DCIT]
Levoarterenol
Levonor
Levonoradrenaline
Levonorepinephrine
Levophed
Levophed bitartrate
L-noradrenaline
|
L-Noradrenaline
L-Norepinephrine
L-NOREPINEPHRINE
LS-42676
LT03330026
LT4
NCGC00159406-02
NCGC00159406-03
NCGC00159406-04
NCGC00159406-05
NCGC00159406-06
NCGC00159406-07
NCGC00159406-09
nchembio.284-comp2
nchembio.64-comp2
nchembio705-1
NINDS_000230
Nor adrenalin
Nor adrenalin (TN)
Noradrenalin
Noradrenalina
Noradrenalina [Italian]
noradrenaline
Noradrenaline
Nor-adrenaline
Noradrenaline (JP15)
Noradrenaline bitartrate
Noradrénaline tartrate renaudin
Noradrenalinum
Norartrinal
Noreinefrina
Noreinefrina [INN-Spanish]
norepinefrina
Norepinefrina
Norepinephrin D-tartrate (1:1)
norepinephrine
Norepinephrine
Norepinephrine (INN)
Norepinephrine [INN:JAN]
Norepinephrine bitartrate
Norepinephrine D-tartrate (1:1)
Norepinephrine hydrochloride
Norepinephrine hydrochloride, (+)-isomer
Norepinephrine hydrochloride, (+,-)-isomer
Norepinephrine l-Tartrate (1:1)
Norepinephrine L-tartrate (1:1)
Norepinephrine L-tartrate (1:1), (+,-)-isomer
Norepinephrine L-tartrate (1:1), monohydrate
Norepinephrine L-tartrate (1:1), monohydrate, (+)-isomer
Norepinephrine L-tartrate (1:2)
Norepinephrine L-tartrate, (+)-isomer
Norepinephrine Noradrenalin
Norepinephrine, (+)-isomer
Norepinephrine, (+,-)-isomer
norepinephrinum
Norepinephrinum
Norepinephrinum [INN-Latin]
Norepirenamine
Nor-epirenan
PDSP1_001111
PDSP2_001095
Renaudin brand OF norepinephrine bitartrate
Renaudin, noradrénaline tartrate
SGCUT00123
SPBio_001048
Spectrum_001009
SPECTRUM1500436
Spectrum2_001064
Spectrum3_000520
Spectrum4_000078
Spectrum5_001068
STK503776
Sympathin e
Sympathin E
Tartrate renaudin, noradrénaline
to_000024
UNII-X4W3ENH1CV
|
|
36 |
|
Keratolytic Agents |
|
Phase 1, Phase 2,Phase 2,Early Phase 1,Not Applicable |
|
|
|
37 |
|
Anti-Infective Agents |
|
Phase 1, Phase 2,Phase 2,Early Phase 1,Not Applicable |
|
|
|
38 |
|
Antifungal Agents |
|
Phase 1, Phase 2,Phase 2,Early Phase 1,Not Applicable |
|
|
|
39 |
|
Dermatologic Agents |
|
Phase 1, Phase 2,Phase 2,Early Phase 1,Not Applicable |
|
|
|
40 |
|
Cortisol succinate |
|
Phase 2,Early Phase 1 |
|
|
|
41 |
|
Hydrocortisone 17-butyrate 21-propionate |
|
Phase 2,Early Phase 1 |
|
|
|
42 |
|
Dopamine Agents |
|
Phase 2,Not Applicable |
|
|
|
43 |
|
Sympathomimetics |
|
Phase 2,Not Applicable |
|
|
|
44 |
|
Adrenergic Agents |
|
Phase 2,Not Applicable |
|
|
|
45 |
|
Antipsychotic Agents |
|
Phase 2 |
|
|
|
46 |
|
Quetiapine Fumarate |
|
Phase 2 |
|
111974-72-2 |
|
47 |
|
Autonomic Agents |
|
Phase 2,Not Applicable |
|
|
|
48 |
|
Adrenergic alpha-Agonists |
|
Phase 2 |
|
|
|
49 |
|
Serotonin and Noradrenaline Reuptake Inhibitors |
|
Phase 2 |
|
|
|
50 |
|
Adrenergic Agonists |
|
Phase 2 |
|
|
|
Interventional clinical trials:
(show top 50)
(show all 55)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Effects of Botulinum Toxin Type A(Meditoxin®) on Sleep Bruxism |
Unknown status |
NCT01336439
|
Phase 4 |
Botulinum toxin type A (Meditoxin®) |
2 |
Study of the Safety and Efficacy of Botox in Bruxism |
Unknown status |
NCT00908050
|
Phase 4 |
Botulinum toxin type A |
3 |
Accuracy and Efficacy of Trazodone (Desyrel) on Sleep Quality and Pain Management of TMD Patient |
Not yet recruiting |
NCT03522207
|
Phase 4 |
Trazodone;Placebos;Trazodone;placebos |
4 |
Efficacy of Botulinum Toxin Versus Lidocaine in Treating Masticatory Myofascial Face Pain Using Ultrasound and EMG Guided Techniques |
Terminated |
NCT00992108
|
Phase 4 |
lidocaine;chemodenervation |
5 |
Efficacy of Phytolacca Decandra and Melissa Officinalis in Children With Nocturnal Bruxism |
Unknown status |
NCT02870543
|
Phase 3 |
Phytolacca decandra;Melissa officinalis;Phyt.decandra + Melissa offic. |
6 |
Postoperative Hypersensitivity Randomized Comparative Effectiveness Research Trial |
Completed |
NCT01268605
|
Phase 3 |
|
7 |
The Platelet-Rich Plasma in the Therapy of Temporomandibular Disorders |
Completed |
NCT03371888
|
Phase 2, Phase 3 |
|
8 |
The Influence of Oral Vibrational Stimulation on Cognitive Function of Elderly Individuals |
Unknown status |
NCT02332525
|
Phase 1, Phase 2 |
|
9 |
Physiotherapy on the Airway of Bruxist Children |
Completed |
NCT01178229
|
Phase 1, Phase 2 |
|
10 |
Occlusal Adjustment as Treatment for Chronic Orofacial Pain |
Completed |
NCT00899717
|
Phase 1, Phase 2 |
|
11 |
Evaluation of the Effectiveness of Infrared LED Photobiomodulation in Children With Sleep Bruxism |
Recruiting |
NCT03710174
|
Phase 2 |
|
12 |
A Study to Compare the Efficacy, Safety, and Tolerability of JNJ-42847922 Versus Quetiapine Extended-Release as Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy |
Recruiting |
NCT03321526
|
Phase 2 |
JNJ-42847922;Placebo Matching to JNJ-42847922;Quetiapine XR;Placebo Matching to Quetiapine XR;Selective Serotonin Reuptake Inhibitor (SSRI);Serotonin-Norepinephrine Reuptake Inhibitor (SNRI) |
13 |
A Study to Assess the Effect of Seltorexant Compared to Placebo on Respiration During Sleep in Adult Participants With Obstructive Sleep Apnea |
Recruiting |
NCT03796026
|
Phase 1 |
Seltorexant 40 mg;Placebo |
14 |
Botox for Treatment of TMJ Disorder With Bruxism |
Withdrawn |
NCT02202070
|
Phase 1 |
onabotulinumtoxinA |
15 |
Evaluation of Muscle Activity, Bite Force and Salivary Cortisol in Children With Bruxism |
Unknown status |
NCT02757261
|
Early Phase 1 |
|
16 |
Physical Therapy Interventions Relative to Dental Treatment in Individuals With Bruxism |
Unknown status |
NCT01778881
|
Not Applicable |
|
17 |
Relationship of Facial Pattern With Bruxism |
Unknown status |
NCT00868244
|
|
|
18 |
TMJ NextGen Pilot Study to Treat Subjects With Bruxism |
Unknown status |
NCT02446288
|
Not Applicable |
|
19 |
Reduction of Masticatory Muscle Activity by Restoring Canine Guidance |
Unknown status |
NCT02235220
|
Not Applicable |
|
20 |
Analysis of the Prevalence and Characteristics of Concomitant Sleep and Headache Disorders, and the Efficacy of CPAP Treatment for Headache Among Those Patients Diagnosed With Obstructive Sleep Apnea |
Unknown status |
NCT00520156
|
|
|
21 |
The Effects of Proprioceptive Neuromuscular Facilitation, Myofascial Releasing Maneuvers and Home Exercises on Pain and Jaw Function in Patients With Bruxism |
Completed |
NCT03499665
|
Not Applicable |
|
22 |
Respiratory Problems and Caries in Children With Bruxism |
Completed |
NCT01463826
|
|
|
23 |
Treatment Sleep Bruxism With the Luco Hybrid OSA Appliance |
Completed |
NCT02882880
|
Not Applicable |
|
24 |
Floral Remedies for Sleep-bruxism Patients |
Completed |
NCT03112954
|
Not Applicable |
Buccal-relaxant formula;Placebo |
25 |
Comparative Evaluation of Gabapentine and Occlusal Splint in the Management of Sleep Bruxism |
Completed |
NCT01255878
|
Not Applicable |
Gabapentine |
26 |
TMJ NextGeneration(TM) Feasibility Study |
Completed |
NCT02257320
|
Not Applicable |
|
27 |
Effects of the Continuous Wear of Invisalign® Trays on the Temporomandibular Joints and Orofacial Muscular Complex |
Completed |
NCT01812850
|
|
|
28 |
Efficacy of Physiotherapy in Patients With Bruxism. |
Completed |
NCT03555201
|
Not Applicable |
|
29 |
Nocturnal Mouth Guards, SOVA vs. Standard Acrylic Orthotic; Phase IV |
Completed |
NCT02340663
|
Not Applicable |
|
30 |
Effects of Dry Needling in Patients With Sleep Bruxism and Temporomandibular Disorders: a Prospective Case Series |
Completed |
NCT02587182
|
Not Applicable |
|
31 |
A Clinical Trial of the Optimal Treatment Period and Long-term Efficacy of Functional Electrical Stimulation (FES) on Sleep Bruxism |
Completed |
NCT01000389
|
Not Applicable |
|
32 |
Oral Appliance in Obstructive Sleep Apnea. A Randomized Controlled Blinded Multicenter Study Comparing Two Devices |
Completed |
NCT02148510
|
Not Applicable |
|
33 |
Impact of an Intensive Multimodal Educative Program on Behavioral Disorders of Patients With Profound Multiple Disabilities and on the Quality of Life and Feelings of Caregivers |
Completed |
NCT02510846
|
Not Applicable |
|
34 |
Alterations in Subgingival Microbiota and Hypoxia in Occlusal Trauma |
Completed |
NCT03621891
|
|
|
35 |
Conservative Treatment of Patients With Temporomandibular Disorders |
Completed |
NCT01021306
|
Not Applicable |
|
36 |
Prevalence of Bruxism in a Group of Preschool Egyptian Children |
Recruiting |
NCT03006133
|
|
|
37 |
All-ceramic Crowns in Patients With Sleep Bruxism |
Recruiting |
NCT03039985
|
Not Applicable |
|
38 |
Clinical Efficacy of Crowns Fabricated Using LuxaCrown |
Recruiting |
NCT03160950
|
Not Applicable |
|
39 |
A Full-Arch Implant- Supported Prosthesis in the Upper and/or Lower Jaw-USA |
Recruiting |
NCT03655990
|
|
|
40 |
Temporomandibular Dysfunction in Patients With Tinnitus: Assessment and Treatment |
Recruiting |
NCT03209297
|
Not Applicable |
|
41 |
Clinical Performance of a Glass Hybrid Restorative in NCCL's of Patients With Bruxism |
Active, not recruiting |
NCT03713827
|
Not Applicable |
|
42 |
Sleep Bruxism and (Peri-)Implant Complications |
Active, not recruiting |
NCT02410681
|
|
|
43 |
Evaluation of Selected Disorders With Sleep Bruxism |
Enrolling by invitation |
NCT03083405
|
|
Clonidine;Buspirone |
44 |
OstiSense Biosensor in Bruxism Reduction - A Clinical Study |
Not yet recruiting |
NCT03749928
|
Not Applicable |
|
45 |
Validation of a Diagnostic Method for Quantification of Sleep Bruxism |
Not yet recruiting |
NCT03325920
|
Not Applicable |
|
46 |
Interest of the BRUXENSE Occlusal Splints for Bruxism Diagnosis: a Feasibility Study |
Not yet recruiting |
NCT03363204
|
Not Applicable |
|
47 |
Evaluation of Biofeedback Therapy Efficiency in Sleep Bruxism and Masticatory Muscles Pain Management |
Not yet recruiting |
NCT03421028
|
Not Applicable |
|
48 |
Association Between Obstructive Sleep Apnea and Bruxism |
Not yet recruiting |
NCT03810248
|
|
|
49 |
Aspects Associated With Obstructive Sleep Apnea, Bruxism and Orofacial Pain |
Not yet recruiting |
NCT03766464
|
|
|
50 |
Aspects Associated With Sleep Quality |
Not yet recruiting |
NCT03766477
|
|
|
Cochrane evidence based reviews: bruxism
|